Coagulopathy, injury severity and bleeding progression but not prior antiplatelet and anticoagulation therapies drive prognosis in patients with moderate to severe traumatic brain injury

IntroductionAntiplatelet and anticoagulant therapies complicate the management and outcomes of traumatic brain injury (TBI) patients. This study evaluates clinical profiles and short-term outcomes focusing on prior antihemostatic therapy and tranexamic acid (TXA) use.Patients and methodsWe analyzed...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Franziska Lieschke, Daniel T. Marggrander, Konstantin D. Kohlhase, Daniel Touma, Jan Hendrik Schaefer, Sarah C. Reitz, Juergen Konczalla, Cora R. Schindler, Christian Grefkes, Ferdinand O. Bohmann
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2025-07-01
Reeks:	Frontiers in Neurology
Onderwerpen:	traumatic brain injury anticoagulation (dual) antiplatelet therapy intracranial hemorrhage demographic change falls
Online toegang:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1592583/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!